[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "depression disorder and genes ber1 and ber2 in humans. To further verify those findings the researchers obtained the mice lines: \ndeltaber1 \u2013 where two alleles of ber1 gene were knock out.\ndeltaber2- where two alleles of ber2 gene were knock out.\ndelta-ber1, delta-ber2- where both two alleles of ber1 and ber2 were knock out.\n\nTo assess locomotor activity anxiety-related behavior mice were placed in the novel opened field for 1 hour. The time spent in the center of the field and the distance they moved in 5-minute intervals were measured for all the mice lines:\nWild-type line: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\ndelta-ber2: time spent in the center \u2013 8%, distance moved \u2013 average 1250 cm/5minutes.\ndelta-ber1, delta-ber2: time spent in the center \u2013 8%, distance moved -average 1250 cm/5minutes.\n\nNext, the forced swimming test was performed the immobility time was measured over six minutes the results are shown below:\nWild-type line: immobility time \u2013 180 seconds\ndelta-ber1:  immobility time \u2013 180 seconds\ndelta-ber2: immobility time - 230 seconds\ndelta-ber1, delta-ber2: immobility time \u2013 230 seconds\n\nFinally, the sucrose preference test was performed. After acclimation, the two bottles were provided to the mice. One with plain water and the second with 1% sucrose. After 24 hours the percentage of sucrose consumption was calculated. The sucrose preference was calculated as a percentage of total fluid intake that was from the sucrose solution. The results are shown below:\nWild-type line: sucrose preference - 75%\ndelta-ber1: sucrose preference - 62%\ndelta-ber2: sucrose preference - 62%\ndelta-ber1, delta-ber2: sucrose preference - 62%\n\nIn the molecular test, the researchers tested the expression of endogenous proliferative marker Ki67 in the dentate gyrus region in the brain of the tested mice. The cells showing expression of the Ki67 in the dentate gyrus were calculated. The numbers are presented below:\nWild-type line: 3500\ndelta-ber1: 3500\ndelta-ber2: 3500\ndelta-ber1, delta-ber2: 2850\n\nIn the pharmacological experiment the mice lines were administered with escitalopram for two weeks then the novel field experiment was performed. The data are shown below:\nWild-type line: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\ndelta-ber2: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1, delta-ber2: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\n\n\nAnswer Choices:\nA. The effects of mutations in ber1 and ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nB. None of the above is correct. \nC. The effect of mutations in ber2 and ber1 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Ber1 and ber2 may have redundant functions. Only mutation in ber2 causes anxiety in the mice. Gene ber2 regulates cell proliferation.\nD. The effects of mutations in ber 1 and ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Defects in ber2 do not always cause a decrease in cell proliferation.\nE. The effects of mutations in ber2 may not be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nF. Defects in ber2 always cause anhedonia and a decrease in cell proliferation. Defects in ber2 always result in anhedonia, anxiety and a decrease cell proliferation.\nG. The effects of mutations in ber2 will be always reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nH. The effects of mutations in ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation. Anhedonia can be treated with SSRIs."
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762207370-sbvNRxmptBXKEMAv7oBG",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"A\\n\\nReasoning: Deleting ber2 (alone or with ber1) produces anxiety-like (less center time, increased locomotion) and depression-like behaviors (greater immobility, reduced sucrose preference), and these open-field effects are normalized by escitalopram (SSRI). Ki67 counts are unchanged in either single knockout but are reduced only in the double knockout, indicating ber1 and ber2 together regulate cell proliferation (redundant function) and that loss of ber2 alone does not necessarily reduce proliferation.\",\"answer_letter\":\"A\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Analyzing gene functions**\n\nI'm reflecting on the idea that \"mutations in ber1 and ber2 may be reversed.\" It seems delber1 showed no phenotype, but SSRIs did reverse the delber2 phenotype. So, implying both can be reversed feels a bit misleading since delber1 doesn't have anything to reverse. It's true that defects in ber2 might not affect cell proliferation, and while both genes regulate that, it's only the mutation in ber2 that causes anxiety in mice. I need to clarify that ber1 and ber2 together are responsible for regulating cell proliferation.**Evaluating gene claims**\n\nI see that statement C inaccurately claims only ber2 causes anxiety, omitting that delber1 had none. The first part's okay, but the claim about cell proliferation is incorrect. Statement D is accurate that defects in ber2 don\u2019t always lead to decreased proliferation, but it misses mentioning redundancy or regulation. Checking the initial statement about SSRI's ability to reverse mutations in ber1 and ber2 is ambiguous. Lastly, statement E incorrectly claims that SSRIs may not reverse the effects of mutations in ber2, which contradicts the data showing SSRIs reversed the delber2 phenotype.**Comparing findings on ber2**\n\nI'm examining the statement that mice with defects in ber2 may not have reduced cell proliferation, and that genes ber1 and ber2 regulate it. The word \"always\" feels too strong; data only indicate reversal in open field contexts, which makes \"always\" seem absolute. Looking at statement H, it claims SSRIs can reverse mutations in ber2, which also seems accurate since SSRIs have shown effects on anxiety and hyperactivity. However, while anhedonia is often treated with SSRIs, it's not always effective, leading to the need for careful comparison between statements H, A, and D.**Evaluating options for mutations**\n\nI'm trying to determine which option fits best based on key observations. Delber2 causes anxiety, increased immobility, and anhedonia since sucrose preference is decreased, while delber1 shows anhedonia without anxiety or immobility. Single knockouts don\u2019t reduce proliferation, only the double knockout does, indicating redundancy. The SSRI escitalopram seems to reverse deficits in both delber2 and the double knockout. So, option H's claim that SSRI can reverse ber2 mutations seems correct, while option A's ambiguity and lack of redundancy details feel less strong.**Comparing options on ber genes**\n\nOption A states, \"Mice with defects in ber2 may not have a decrease in cell proliferation,\" which is close but not explicit about redundancy. It mentions that both genes regulate proliferation, while option H adds that anhedonia is treatable with SSRIs. However, that's not shown in the data. Option C discusses redundancy, but it inaccurately states that only ber2 causes anxiety. Option D is conservative and accurate but lacks the regulation detail. Ultimately, option A appears most comprehensive, mentioning gene regulation while acknowledging potential variations in cell proliferation. So I'm leaning toward selecting A.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Analyzing gene functions**\n\nI'm reflecting on the idea that \"mutations in ber1 and ber2 may be reversed.\" It seems delber1 showed no phenotype, but SSRIs did reverse the delber2 phenotype. So, implying both can be reversed feels a bit misleading since delber1 doesn't have anything to reverse. It's true that defects in ber2 might not affect cell proliferation, and while both genes regulate that, it's only the mutation in ber2 that causes anxiety in mice. I need to clarify that ber1 and ber2 together are responsible for regulating cell proliferation.**Evaluating gene claims**\n\nI see that statement C inaccurately claims only ber2 causes anxiety, omitting that delber1 had none. The first part's okay, but the claim about cell proliferation is incorrect. Statement D is accurate that defects in ber2 don\u2019t always lead to decreased proliferation, but it misses mentioning redundancy or regulation. Checking the initial statement about SSRI's ability to reverse mutations in ber1 and ber2 is ambiguous. Lastly, statement E incorrectly claims that SSRIs may not reverse the effects of mutations in ber2, which contradicts the data showing SSRIs reversed the delber2 phenotype.**Comparing findings on ber2**\n\nI'm examining the statement that mice with defects in ber2 may not have reduced cell proliferation, and that genes ber1 and ber2 regulate it. The word \"always\" feels too strong; data only indicate reversal in open field contexts, which makes \"always\" seem absolute. Looking at statement H, it claims SSRIs can reverse mutations in ber2, which also seems accurate since SSRIs have shown effects on anxiety and hyperactivity. However, while anhedonia is often treated with SSRIs, it's not always effective, leading to the need for careful comparison between statements H, A, and D.**Evaluating options for mutations**\n\nI'm trying to determine which option fits best based on key observations. Delber2 causes anxiety, increased immobility, and anhedonia since sucrose preference is decreased, while delber1 shows anhedonia without anxiety or immobility. Single knockouts don\u2019t reduce proliferation, only the double knockout does, indicating redundancy. The SSRI escitalopram seems to reverse deficits in both delber2 and the double knockout. So, option H's claim that SSRI can reverse ber2 mutations seems correct, while option A's ambiguity and lack of redundancy details feel less strong.**Comparing options on ber genes**\n\nOption A states, \"Mice with defects in ber2 may not have a decrease in cell proliferation,\" which is close but not explicit about redundancy. It mentions that both genes regulate proliferation, while option H adds that anhedonia is treatable with SSRIs. However, that's not shown in the data. Option C discusses redundancy, but it inaccurately states that only ber2 causes anxiety. Option D is conservative and accurate but lacks the regulation detail. Ultimately, option A appears most comprehensive, mentioning gene regulation while acknowledging potential variations in cell proliferation. So I'm leaning toward selecting A.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_0da636c7ad002c96016909268be9a0819483eae03045717fad",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762207370,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 2172,
        "prompt_tokens": 1112,
        "total_tokens": 3284,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 2048,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 1024
        },
        "cost": 0.0043916,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 4.76e-05,
          "upstream_inference_completions_cost": 0.004344
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "depression disorder and genes ber1 and ber2 in humans. To further verify those findings the researchers obtained the mice lines: \ndeltaber1 \u2013 where two alleles of ber1 gene were knock out.\ndeltaber2- where two alleles of ber2 gene were knock out.\ndelta-ber1, delta-ber2- where both two alleles of ber1 and ber2 were knock out.\n\nTo assess locomotor activity anxiety-related behavior mice were placed in the novel opened field for 1 hour. The time spent in the center of the field and the distance they moved in 5-minute intervals were measured for all the mice lines:\nWild-type line: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\ndelta-ber2: time spent in the center \u2013 8%, distance moved \u2013 average 1250 cm/5minutes.\ndelta-ber1, delta-ber2: time spent in the center \u2013 8%, distance moved -average 1250 cm/5minutes.\n\nNext, the forced swimming test was performed the immobility time was measured over six minutes the results are shown below:\nWild-type line: immobility time \u2013 180 seconds\ndelta-ber1:  immobility time \u2013 180 seconds\ndelta-ber2: immobility time - 230 seconds\ndelta-ber1, delta-ber2: immobility time \u2013 230 seconds\n\nFinally, the sucrose preference test was performed. After acclimation, the two bottles were provided to the mice. One with plain water and the second with 1% sucrose. After 24 hours the percentage of sucrose consumption was calculated. The sucrose preference was calculated as a percentage of total fluid intake that was from the sucrose solution. The results are shown below:\nWild-type line: sucrose preference - 75%\ndelta-ber1: sucrose preference - 62%\ndelta-ber2: sucrose preference - 62%\ndelta-ber1, delta-ber2: sucrose preference - 62%\n\nIn the molecular test, the researchers tested the expression of endogenous proliferative marker Ki67 in the dentate gyrus region in the brain of the tested mice. The cells showing expression of the Ki67 in the dentate gyrus were calculated. The numbers are presented below:\nWild-type line: 3500\ndelta-ber1: 3500\ndelta-ber2: 3500\ndelta-ber1, delta-ber2: 2850\n\nIn the pharmacological experiment the mice lines were administered with escitalopram for two weeks then the novel field experiment was performed. The data are shown below:\nWild-type line: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\ndelta-ber2: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1, delta-ber2: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\n\n\nAnswer Choices:\nA. The effects of mutations in ber1 and ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nB. None of the above is correct. \nC. The effect of mutations in ber2 and ber1 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Ber1 and ber2 may have redundant functions. Only mutation in ber2 causes anxiety in the mice. Gene ber2 regulates cell proliferation.\nD. The effects of mutations in ber 1 and ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Defects in ber2 do not always cause a decrease in cell proliferation.\nE. The effects of mutations in ber2 may not be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nF. Defects in ber2 always cause anhedonia and a decrease in cell proliferation. Defects in ber2 always result in anhedonia, anxiety and a decrease cell proliferation.\nG. The effects of mutations in ber2 will be always reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nH. The effects of mutations in ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation. Anhedonia can be treated with SSRIs."
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762207370-0NMSa4GTVlugDZbKyIOP",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"A\\n\\nReasoning (brief): Deleting ber2 (alone or with ber1) produces anxiety-like/open-field and increased immobility (depression-like) and anhedonia, and escitalopram restored the open-field measures, so SSRI can reverse the behavioral effects measured. Ki67 counts are unchanged in single ber1 or ber2 KOs but reduced only in the double KO, indicating loss of both genes reduces proliferation (i.e., single ber2 may not show decreased proliferation). Thus A best fits the data.\",\"answer_letter\":\"A\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Analyzing experimental results**\n\nI need to interpret experimental data. In the open field test, both WT and delta-ber1 showed normal behavior, while delta-ber2 and double mutants had increased anxiety and hyperactivity. The forced swim test suggested increased immobility in certain mutants, indicating depressive-like behaviors. Sucrose preference showed all mutants displayed anhedonia. Interestingly, delta-ber1's other results seem normal despite this. Regarding cell proliferation, only the double mutants showed a decrease. After treatment with escitalopram, most behavior normalized, suggesting SSRIs effectively reverse anxiety and hyperactivity.**Examining mutation effects and treatment**\n\nI\u2019m looking at the key findings from the mutations. The ber2 mutation leads to anxiety, increased movement, and signs of depression and anhedonia, which is also present in delta-ber1. The treatment with escitalopram reversed some deficits in the open field tests for delta-ber2 and double mutants, indicating that SSRIs can help with anxiety and hyperactivity. However, because they only tested the open field after the SSRI treatment, I can't definitively say that SSRIs reverse all issues, like anhedonia or results from the forced swim test. Regarding cell proliferation, only the double mutation showed decreased Ki67 levels; the single knockouts didn't show this decrease.**Clarifying gene functions and redundancies**\n\nThe statement about \"Mice with defects in ber2 not decreasing cell proliferation\" is true since delta-ber2 showed similar levels to WT at 3500. It seems that genes ber1 and ber2 may regulate cell proliferation together, as evidenced by only the double mutation reducing proliferation, suggesting redundancy. Thus, claiming they regulate proliferation isn't wrong. For the options, Option C correctly states that ber1 and ber2 may have redundant functions. However, the statement \u201cgene ber2 regulates cell proliferation\u201d is misleading since the data show that the single mutation did not reduce proliferation. Option H claims mice with ber2 mutations may not show decreased proliferation and that SSRIs can treat anhedonia.**Evaluating mutation and treatment options**\n\nThe claim about SSRIs treating anhedonia is unsupported, as they were only tested after open field assessments. So, Option H is incorrect. In Option G, saying that effects of mutations in ber2 \"will always be reversed\" by SSRIs is too strong; the data only show reversal in open field results. Option A states that mutations in ber1 and ber2 may have reversible effects, and while it acknowledges that ber2 mutants don\u2019t show decreased proliferation, it doesn't mention the redundancy of these genes. However, it\u2019s still mostly correct in asserting that they regulate proliferation.**Choosing the best option**\n\nI need to check the early data where delta-ber1 showed decreased sucrose preference, indicating anhedonia, but without changes in anxiety or forced swim behavior. This suggests that ber1 influences reward alone. Now, looking at Option D, it claims mutations in ber1 and ber2 can be reversed by SSRIs, which is partly true since SSRIs reversed some behaviors, and it accurately states that defects in ber2 don\u2019t always lead to decreased cell proliferation. Option A states that ber1 and ber2 regulate proliferation, which is supported by the double mutation data, indicating redundancy. Comparing A and D, A provides a more complete view. Although both mention that ber2 defects may not decrease proliferation, A emphasizes regulation and is closest to the overall findings. Therefore, I'll select Option A, highlighting its nuanced understanding. I'll prepare a concise JSON output with the chosen answer.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Analyzing experimental results**\n\nI need to interpret experimental data. In the open field test, both WT and delta-ber1 showed normal behavior, while delta-ber2 and double mutants had increased anxiety and hyperactivity. The forced swim test suggested increased immobility in certain mutants, indicating depressive-like behaviors. Sucrose preference showed all mutants displayed anhedonia. Interestingly, delta-ber1's other results seem normal despite this. Regarding cell proliferation, only the double mutants showed a decrease. After treatment with escitalopram, most behavior normalized, suggesting SSRIs effectively reverse anxiety and hyperactivity.**Examining mutation effects and treatment**\n\nI\u2019m looking at the key findings from the mutations. The ber2 mutation leads to anxiety, increased movement, and signs of depression and anhedonia, which is also present in delta-ber1. The treatment with escitalopram reversed some deficits in the open field tests for delta-ber2 and double mutants, indicating that SSRIs can help with anxiety and hyperactivity. However, because they only tested the open field after the SSRI treatment, I can't definitively say that SSRIs reverse all issues, like anhedonia or results from the forced swim test. Regarding cell proliferation, only the double mutation showed decreased Ki67 levels; the single knockouts didn't show this decrease.**Clarifying gene functions and redundancies**\n\nThe statement about \"Mice with defects in ber2 not decreasing cell proliferation\" is true since delta-ber2 showed similar levels to WT at 3500. It seems that genes ber1 and ber2 may regulate cell proliferation together, as evidenced by only the double mutation reducing proliferation, suggesting redundancy. Thus, claiming they regulate proliferation isn't wrong. For the options, Option C correctly states that ber1 and ber2 may have redundant functions. However, the statement \u201cgene ber2 regulates cell proliferation\u201d is misleading since the data show that the single mutation did not reduce proliferation. Option H claims mice with ber2 mutations may not show decreased proliferation and that SSRIs can treat anhedonia.**Evaluating mutation and treatment options**\n\nThe claim about SSRIs treating anhedonia is unsupported, as they were only tested after open field assessments. So, Option H is incorrect. In Option G, saying that effects of mutations in ber2 \"will always be reversed\" by SSRIs is too strong; the data only show reversal in open field results. Option A states that mutations in ber1 and ber2 may have reversible effects, and while it acknowledges that ber2 mutants don\u2019t show decreased proliferation, it doesn't mention the redundancy of these genes. However, it\u2019s still mostly correct in asserting that they regulate proliferation.**Choosing the best option**\n\nI need to check the early data where delta-ber1 showed decreased sucrose preference, indicating anhedonia, but without changes in anxiety or forced swim behavior. This suggests that ber1 influences reward alone. Now, looking at Option D, it claims mutations in ber1 and ber2 can be reversed by SSRIs, which is partly true since SSRIs reversed some behaviors, and it accurately states that defects in ber2 don\u2019t always lead to decreased cell proliferation. Option A states that ber1 and ber2 regulate proliferation, which is supported by the double mutation data, indicating redundancy. Comparing A and D, A provides a more complete view. Although both mention that ber2 defects may not decrease proliferation, A emphasizes regulation and is closest to the overall findings. Therefore, I'll select Option A, highlighting its nuanced understanding. I'll prepare a concise JSON output with the chosen answer.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_0ef5c5f6ac435ea9016909268b7d588190be24f5b3b8b96e54",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762207370,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1406,
        "prompt_tokens": 1112,
        "total_tokens": 2518,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1280,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00309,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.000278,
          "upstream_inference_completions_cost": 0.002812
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "depression disorder and genes ber1 and ber2 in humans. To further verify those findings the researchers obtained the mice lines: \ndeltaber1 \u2013 where two alleles of ber1 gene were knock out.\ndeltaber2- where two alleles of ber2 gene were knock out.\ndelta-ber1, delta-ber2- where both two alleles of ber1 and ber2 were knock out.\n\nTo assess locomotor activity anxiety-related behavior mice were placed in the novel opened field for 1 hour. The time spent in the center of the field and the distance they moved in 5-minute intervals were measured for all the mice lines:\nWild-type line: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\ndelta-ber2: time spent in the center \u2013 8%, distance moved \u2013 average 1250 cm/5minutes.\ndelta-ber1, delta-ber2: time spent in the center \u2013 8%, distance moved -average 1250 cm/5minutes.\n\nNext, the forced swimming test was performed the immobility time was measured over six minutes the results are shown below:\nWild-type line: immobility time \u2013 180 seconds\ndelta-ber1:  immobility time \u2013 180 seconds\ndelta-ber2: immobility time - 230 seconds\ndelta-ber1, delta-ber2: immobility time \u2013 230 seconds\n\nFinally, the sucrose preference test was performed. After acclimation, the two bottles were provided to the mice. One with plain water and the second with 1% sucrose. After 24 hours the percentage of sucrose consumption was calculated. The sucrose preference was calculated as a percentage of total fluid intake that was from the sucrose solution. The results are shown below:\nWild-type line: sucrose preference - 75%\ndelta-ber1: sucrose preference - 62%\ndelta-ber2: sucrose preference - 62%\ndelta-ber1, delta-ber2: sucrose preference - 62%\n\nIn the molecular test, the researchers tested the expression of endogenous proliferative marker Ki67 in the dentate gyrus region in the brain of the tested mice. The cells showing expression of the Ki67 in the dentate gyrus were calculated. The numbers are presented below:\nWild-type line: 3500\ndelta-ber1: 3500\ndelta-ber2: 3500\ndelta-ber1, delta-ber2: 2850\n\nIn the pharmacological experiment the mice lines were administered with escitalopram for two weeks then the novel field experiment was performed. The data are shown below:\nWild-type line: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\ndelta-ber2: time spent in the center \u2013 15%, distance moved \u2013 average 900 cm/5minutes.\ndelta-ber1, delta-ber2: time spent in the center \u2013 15%, distance moved -average 900 cm/5minutes.\n\n\nAnswer Choices:\nA. The effects of mutations in ber1 and ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nB. None of the above is correct. \nC. The effect of mutations in ber2 and ber1 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Ber1 and ber2 may have redundant functions. Only mutation in ber2 causes anxiety in the mice. Gene ber2 regulates cell proliferation.\nD. The effects of mutations in ber 1 and ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Defects in ber2 do not always cause a decrease in cell proliferation.\nE. The effects of mutations in ber2 may not be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nF. Defects in ber2 always cause anhedonia and a decrease in cell proliferation. Defects in ber2 always result in anhedonia, anxiety and a decrease cell proliferation.\nG. The effects of mutations in ber2 will be always reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation.\nH. The effects of mutations in ber2 may be reversed by treatment with selective serotonin reuptake inhibitors (SSRI). Mice with defects in ber2 may not have a decrease in cell proliferation.  Gene ber1 and ber2 regulate cell proliferation. Anhedonia can be treated with SSRIs."
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762207370-A72RYFSbSbx1RDZrbW9w",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"A\\n\\nReasoning (concise):\\n- Open-field: deltaber2 (and double) show anxiety-like (less center, hyperactivity); deltaber1 is like WT. After escitalopram, all lines revert to WT open-field values \u2192 SSRI can reverse the behavioral effects. \\n- Forced swim: increased immobility only in deltaber2 (and double) \u2192 depressive-like behavior linked to ber2. \\n- Sucrose preference: both deltaber1 and deltaber2 (and double) show reduced sucrose preference \u2192 anhedonia present with loss of either gene. \\n- Ki67: single KOs (deltaber1, deltaber2) have normal proliferation (3500), only the double shows reduced Ki67 (2850) \u2192 ber1 and ber2 act redundantly to regulate cell proliferation; loss of ber2 alone does not decrease proliferation. \\nThese findings match statement A.\",\"answer_letter\":\"A\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Summarizing findings**\n\nI need to pick the best answer based on the data. The open field baseline shows that WT and deltaber1 are identical with a center percentage of 15%, while deltaber2 and double are at 8%. This implies anxiety-like behavior in the knockout models. The forced swim test indicates increased immobility in deltaber2 and double, suggesting depressive-like behavior. Sucrose preference aligns, with WT at 75% and mutants at 62%, indicating anhedonia. Pharmacological treatment with escitalopram for two weeks seems to have rescued anxiety and hyperlocomotion.**Evaluating SSRI effects**\n\nI'm considering whether SSRIs could rescue behavior in both models. There isn\u2019t data for forced swim or sucrose after SSRI treatment, but I see recovery in the open field, suggesting SSRIs reversed the ber2 phenotype there. I\u2019m checking the options: \n\nOption A suggests that mutations in ber1 and ber2 might be reversed by SSRIs and that defects in ber2 might not affect cell proliferation. The data supports that only the double knockout shows reduced proliferation, indicating redundant roles of both genes. So, A seems plausible, but it's unclear if SSRIs specifically reversed mutations in ber1.**Analyzing mutation effects**\n\nIt seems there was no baseline behavior change in ber1, but SSRIs did return double and ber2 to WT levels. Option A\u2019s initial clause is general but acceptable. Option B seems likely incorrect. For option C, while it claims that SSRIs can reverse mutations in ber1 and ber2, the statement about gene ber2 regulating cell proliferation is problematic since the data shows the single mutation didn\u2019t alter Ki67 levels. Lastly, in option D, the last clause is true, but it omits crucial details about redundancy in functions. Overall, it questions the reversal effects of SSRIs on these mutations.**Evaluating mutation statements**\n\nI\u2019ve observed that option D seems correct based on the open field results. Comparing with option A and H, option E states that the effects of mutations in ber2 may not be reversed by SSRIs, which contradicts the data that SSRIs normalized behavior, so E is wrong. In option F, claiming that defects in ber2 always lead to anhedonia and decreased cell proliferation is inaccurate since while it caused anhedonia and anxiety, it didn\u2019t decrease proliferation. For G, saying the effects will always be reversed by SSRIs feels too absolute even though SSRIs did reverse behaviors in the experiment.**Finalizing answer**\n\nOption H suggests the effects of ber2 mutations may be reversed by SSRIs, but lacks testing evidence for treating anhedonia. So, it's inaccurate. Comparing options A, D, and G, A claims SSRIs may reverse mutations in ber1 and ber2, and the data supports that SSRIs normalized behaviors in the open field. The statement about gene regulation by ber1 and ber2 is accurate as well, supported by the Ki67 data. Thus, A is the best option, as it doesn\u2019t incorrectly state that SSRIs treat anhedonia. I\u2019ll provide this in a concise answer format.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Summarizing findings**\n\nI need to pick the best answer based on the data. The open field baseline shows that WT and deltaber1 are identical with a center percentage of 15%, while deltaber2 and double are at 8%. This implies anxiety-like behavior in the knockout models. The forced swim test indicates increased immobility in deltaber2 and double, suggesting depressive-like behavior. Sucrose preference aligns, with WT at 75% and mutants at 62%, indicating anhedonia. Pharmacological treatment with escitalopram for two weeks seems to have rescued anxiety and hyperlocomotion.**Evaluating SSRI effects**\n\nI'm considering whether SSRIs could rescue behavior in both models. There isn\u2019t data for forced swim or sucrose after SSRI treatment, but I see recovery in the open field, suggesting SSRIs reversed the ber2 phenotype there. I\u2019m checking the options: \n\nOption A suggests that mutations in ber1 and ber2 might be reversed by SSRIs and that defects in ber2 might not affect cell proliferation. The data supports that only the double knockout shows reduced proliferation, indicating redundant roles of both genes. So, A seems plausible, but it's unclear if SSRIs specifically reversed mutations in ber1.**Analyzing mutation effects**\n\nIt seems there was no baseline behavior change in ber1, but SSRIs did return double and ber2 to WT levels. Option A\u2019s initial clause is general but acceptable. Option B seems likely incorrect. For option C, while it claims that SSRIs can reverse mutations in ber1 and ber2, the statement about gene ber2 regulating cell proliferation is problematic since the data shows the single mutation didn\u2019t alter Ki67 levels. Lastly, in option D, the last clause is true, but it omits crucial details about redundancy in functions. Overall, it questions the reversal effects of SSRIs on these mutations.**Evaluating mutation statements**\n\nI\u2019ve observed that option D seems correct based on the open field results. Comparing with option A and H, option E states that the effects of mutations in ber2 may not be reversed by SSRIs, which contradicts the data that SSRIs normalized behavior, so E is wrong. In option F, claiming that defects in ber2 always lead to anhedonia and decreased cell proliferation is inaccurate since while it caused anhedonia and anxiety, it didn\u2019t decrease proliferation. For G, saying the effects will always be reversed by SSRIs feels too absolute even though SSRIs did reverse behaviors in the experiment.**Finalizing answer**\n\nOption H suggests the effects of ber2 mutations may be reversed by SSRIs, but lacks testing evidence for treating anhedonia. So, it's inaccurate. Comparing options A, D, and G, A claims SSRIs may reverse mutations in ber1 and ber2, and the data supports that SSRIs normalized behaviors in the open field. The statement about gene regulation by ber1 and ber2 is accurate as well, supported by the Ki67 data. Thus, A is the best option, as it doesn\u2019t incorrectly state that SSRIs treat anhedonia. I\u2019ll provide this in a concise answer format.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_03db1e93cb286cf2016909268c74e08195a4b3ee15eed411e4",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762207370,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1492,
        "prompt_tokens": 1112,
        "total_tokens": 2604,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1280,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 1024
        },
        "cost": 0.0030316,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 4.76e-05,
          "upstream_inference_completions_cost": 0.002984
        }
      },
      "provider": "OpenAI"
    }
  }
]